Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Therapy for depression may also protect against diabetes in teens

NCT ID NCT03263351

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study looked at whether a type of talk therapy (cognitive-behavioral therapy) could improve how the body uses insulin in teenage girls at risk for type 2 diabetes. The 147 participants were girls aged 12-17 with overweight or obesity, mild to moderate depression, and a family history of diabetes. The therapy group learned to change negative thoughts and increase pleasant activities, while a comparison group received general health education. Researchers measured changes in insulin sensitivity, depression, eating, activity, and sleep over one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cognitive-behavioral therapy (Blues Program)

What this could lead to

If successful, this approach could offer a way to lower type 2 diabetes risk in teenage girls by treating depression.

What could go wrong

This is a completed study with modest size (147 participants) and no phase designation, so results may not apply broadly. The intervention is behavioral, not a drug, so effects may be limited.

Conditions

The condition(s) this trial relates to.

Depression depressive disorder Insulin Resistance Pediatric Obesity type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.